0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anti-Obesity Drugs Market Research Reports

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
CONTRAVE (Naltrexon-Bupropion), Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

CONTRAVE (Naltrexon-Bupropion), Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
EUR$2,750USDGBP
QSYMIA (Phentermine-Topiramate), Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

QSYMIA (Phentermine-Topiramate), Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
EUR$2,750USDGBP
SAXENDA (Liraglutide), Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

SAXENDA (Liraglutide), Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
EUR$2,750USDGBP
IMCIVREE (Setmelanotide), Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

IMCIVREE (Setmelanotide), Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
EUR$2,750USDGBP
Non-Invasive Fat Reduction Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028) - Product Thumbnail Image

Non-Invasive Fat Reduction Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 113 Pages
  • Global
From
EUR$4,750USDGBP
HET Obesity/POMC Deficiency Obesity - Pipeline Insight, 2024 - Product Thumbnail Image

HET Obesity/POMC Deficiency Obesity - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
Hypothalamic Obesity (HO) - Pipeline Insight, 2024 - Product Thumbnail Image

Hypothalamic Obesity (HO) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
Melanocortin 4 Receptor (MC4R) Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Melanocortin 4 Receptor (MC4R) Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
EUR$1,250USDGBP
South Korea Body Fat Reduction Market Report and Forecast 2024-2032 - Product Thumbnail Image

South Korea Body Fat Reduction Market Report and Forecast 2024-2032

  • Report
  • August 2024
  • 160 Pages
  • South Korea
From
EUR$3,599USDGBP
Anti-Obesity Drugs Market Analysis & Forecast 2024-2034: Market By Drug; By Mechanism Of Action; By Route Of Administration; By Distribution Channel; and By Region - Product Thumbnail Image

Anti-Obesity Drugs Market Analysis & Forecast 2024-2034: Market By Drug; By Mechanism Of Action; By Route Of Administration; By Distribution Channel; and By Region

  • Report
  • October 2023
  • 145 Pages
  • Global
From
EUR$3,150USDGBP
Hypothalamic Obesity - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Hypothalamic Obesity - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
EUR$7,500USDGBP
HET Obesity/POMC Deficiency Obesity - Epidemiology Forecast to 2032 - Product Thumbnail Image

HET Obesity/POMC Deficiency Obesity - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Hypothalamic Obesity - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hypothalamic Obesity - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Wegovy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Wegovy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 70 Pages
  • Global
From
EUR$4,750USDGBP
Anti-Obesity Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028) - Product Thumbnail Image

Anti-Obesity Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 137 Pages
  • Global
From
EUR$4,750USDGBP
Non-invasive Fat Reduction Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Non-invasive Fat Reduction Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
EUR$4,150USDGBP
Fat Metaboliser Tablet Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, and Product Type - Product Thumbnail Image

Fat Metaboliser Tablet Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, and Product Type

  • Report
  • January 2024
  • 85 Pages
  • Global
From
EUR$3,956USDGBP
Obesity Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2031 - Product Thumbnail Image

Obesity Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2031

  • Drug Pipelines
  • March 2023
  • 136 Pages
  • Global
From
EUR$14,995USDGBP
Europe Anti-Obesity Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Mechanism of Action, By Route Of Administration (Oral Route and Subcutaneous Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029 - Product Thumbnail Image

Europe Anti-Obesity Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Mechanism of Action, By Route Of Administration (Oral Route and Subcutaneous Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029

  • Report
  • April 2023
  • 83 Pages
  • Europe
From
EUR$1,500USDGBP
Asia Pacific Anti-Obesity Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Mechanism of Action, By Route Of Administration (Oral Route and Subcutaneous Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029 - Product Thumbnail Image

Asia Pacific Anti-Obesity Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Mechanism of Action, By Route Of Administration (Oral Route and Subcutaneous Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029

  • Report
  • April 2023
  • 84 Pages
  • Asia Pacific
From
EUR$1,500USDGBP
Loading Indicator

The Anti-Obesity Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs designed to reduce or prevent obesity. These drugs are typically prescribed to individuals who are overweight or obese and are at risk of developing health complications due to their weight. Commonly prescribed anti-obesity drugs include orlistat, lorcaserin, and phentermine. These drugs work by suppressing appetite, increasing metabolism, or blocking the absorption of fat. The Anti-Obesity Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include GlaxoSmithKline, Novo Nordisk, Sanofi, Pfizer, and Merck. These companies are constantly developing new drugs and treatments to meet the needs of their customers. Show Less Read more